Barinthus Biotherapeutics plc (BRNS) Misses Q2 EPS by 3c

Barinthus Biotherapeutics plc (NASDAQ: BRNS) reported Q2 EPS of ($0.43), $0.03 worse than the analyst estimate of ($0.40).

For earnings history and earnings-related data on Barinthus Biotherapeutics plc (BRNS) click here.

You May Also Be Interested In

• Samsara Inc (IOT) call put ratio 4.5 calls to 1 put with a focus on September 4 weekly calls into quarter results
• Palantir (PLTR) September 4 weekly 187.50 and 192.50 calls as share price up 7%
• Cliffwater Private Credit Fund Sees 16% Redemption Requests - Bloomberg